Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients ...

Among patients who have myasthenia gravis, even low disease activity can impact their quality of life (QOL) via motor ...

Long-term exposure to pollutants was linked to higher psoriasis risk, especially in people with genetic predispositions.

As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, ...

An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, ...

Hair and scalp disorders in patients with skin of color are frequently misdiagnosed, often due to educational gaps and ...

Individuals who used smokeless tobacco and e-cigarettes had an increased risk of developing age-related macular degeneration ...

Physicians were more likely to include terms that undermine the competence and sincerity of Black patients' claims when ...

Emilie Aschenbrenner, PharmD, BCOP, discusses how integrating CD38-targeted therapies into first-line treatment for transplant-ineligible multiple myeloma requires balancing clinical benefit, cost, ...

High stigma due to HIV was also associated with depression and drug use, making the reduction in stigma vital for improving the care of women with HIV.

Jason Bergsbaken, PharmD, MBA, BCOP, explains the value of pharmacist involvement in precision molecular tumor boards and end-of-life care discussions, highlighting their role in ensuring ...

Clayton Irvine, PharmD, MBA, MS, discusses strategies to address payer-driven biosimilar and prior authorization challenges through integrated digital solutions, while advocating for flexible, ...